FRANCIOTTA, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 1.479
EU - Europa 893
AS - Asia 880
SA - Sud America 138
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.415
Nazione #
US - Stati Uniti d'America 1.442
CN - Cina 359
SG - Singapore 266
IE - Irlanda 220
RU - Federazione Russa 163
HK - Hong Kong 123
DE - Germania 122
BR - Brasile 111
FI - Finlandia 111
IT - Italia 86
VN - Vietnam 47
GB - Regno Unito 44
IN - India 27
UA - Ucraina 22
ES - Italia 20
CA - Canada 19
BE - Belgio 17
JP - Giappone 15
MX - Messico 13
PL - Polonia 13
AR - Argentina 12
AT - Austria 12
FR - Francia 12
CZ - Repubblica Ceca 11
SE - Svezia 11
BD - Bangladesh 8
IQ - Iraq 7
MA - Marocco 7
ZA - Sudafrica 7
EC - Ecuador 5
NL - Olanda 5
IR - Iran 4
LT - Lituania 4
PK - Pakistan 4
PT - Portogallo 4
PY - Paraguay 4
TR - Turchia 4
JO - Giordania 3
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
KE - Kenya 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
VE - Venezuela 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.415
Città #
Dublin 220
Chandler 219
Ashburn 173
Singapore 156
Dallas 133
Hong Kong 123
Beijing 89
Helsinki 70
Boardman 66
Munich 63
San Jose 57
Los Angeles 54
Jacksonville 47
New York 42
Nanjing 40
Moscow 33
Lawrence 31
Princeton 31
Medford 26
Shanghai 24
Wilmington 24
Ho Chi Minh City 21
Redondo Beach 21
Shenyang 21
Ann Arbor 20
Nanchang 20
Turku 20
Buffalo 18
Brussels 17
São Paulo 17
Tokyo 15
Rome 14
Hebei 13
Montreal 13
Jiaxing 12
Changsha 11
Hanoi 11
Brooklyn 10
Milan 10
Pune 10
Brno 9
London 9
San Francisco 9
Santa Clara 9
Seattle 9
Warsaw 9
Chicago 8
Stockholm 8
Düsseldorf 7
Falkenstein 7
Frankfurt am Main 7
Houston 7
Manchester 7
Orem 7
Tianjin 7
Denver 6
Fairfield 6
Madrid 6
Nuremberg 6
Pavia 6
Woodbridge 6
Atlanta 5
Guangzhou 5
Hangzhou 5
Poplar 5
Asunción 4
Bologna 4
Boston 4
Mexico City 4
New Delhi 4
Piscataway 4
Secaucus 4
The Dalles 4
Verona 4
Baghdad 3
Berlin 3
Cambridge 3
Cape Town 3
Casablanca 3
Changchun 3
Chennai 3
Dearborn 3
Florence 3
Fortaleza 3
Hefei 3
Hyderabad 3
Jinan 3
Johannesburg 3
Milwaukee 3
Mumbai 3
Phoenix 3
Rio de Janeiro 3
Seveso 3
Washington 3
Xi'an 3
'Asir Region 2
Amman 2
Annapolis 2
Auckland 2
Belo Horizonte 2
Totale 2.299
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 146
Meningeal melanomatosis: a challenge for timely diagnosis. 121
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 117
Inverse association between multiple sclerosis and respiratory allergic diseases 116
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 111
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 108
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 107
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 105
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 103
Diagnostics of anti-MAG antibody polyneuropathy 101
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 99
Air pollution as a contributor to the inflammatory activity of multiple sclerosis 99
Diagnostics of dysimmune peripheral neuropathies 98
Lack of antibodies to neuropil antigens in idiopathic REM sleep behavior disorder 95
Cranial nerve palsies in patients with hematological malignancies: a case series 94
Guillain-Barré syndrome associated with SARS-CoV-2 92
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 91
Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. 86
Gender difference and autoimmune disease: a study of polymorphic MHC genomic markers in myasthenia gravis (MG) 85
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 83
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy 82
Measurement of skeletal muscle mass in Duchenne muscular disease: usefulness of 24-hour creatinine excretion 80
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 79
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 77
Genetic basis for idiosyncratic reactions to antiepileptic drugs. 75
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 73
Ceftazidime/avibactam neurotoxicity in an adult patient with normal renal function 72
Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient 69
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 68
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy (PLoS ONE (2019) 14: 2 (e0212647) DOI: 10.1371/journal.pone.0212647) 68
Polymorphic markers in MHC class II/III region: a study on Italian patients with myastenia gravis 61
Immunohistochemical characterization of a new atypic antibody in a paraneoplastic neurological syndromes. 58
Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis 58
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 51
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 50
Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells 50
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 50
Improving laboratory diagnostics in myasthenia gravis 48
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 46
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 46
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 42
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 39
Impact of seizures and their prophylaxis with antiepileptic drugs on rehabilitation course of patients with traumatic or hemorrhagic brain injury 38
null 21
Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes 20
Totale 3.478
Categoria #
all - tutte 15.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 2 32 7 11 5 5
2021/2022148 5 1 3 2 5 4 3 7 12 3 21 82
2022/2023614 56 56 4 58 41 60 0 27 270 10 24 8
2023/2024314 33 45 3 20 14 77 12 36 0 14 14 46
2024/2025912 44 48 41 19 30 68 48 36 234 51 86 207
2025/20261.134 141 114 188 271 275 93 52 0 0 0 0 0
Totale 3.478